Related Experiment Video
Updated: Jun 10, 2026

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
Published on: March 7, 2025
GABAB-GIRK2-mediated signaling in Down syndrome
Nathan P Cramer1, Tyler K Best, Marcus Stoffel
1Department of Anatomy, Physiology, and Genetics, School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
Down syndrome (DS) involves an extra chromosome 21, causing neurological changes. Overexpression of the GIRK2 gene and its link to GABA(B) receptors may explain some DS disabilities.
Area of Science:
- Genetics and Neuroscience
- Molecular Biology
- Developmental Disorders
Background:
- Down syndrome (DS) is caused by trisomy of chromosome 21, leading to altered gene expression and neurological deficits.
- The precise mechanisms linking trisomic gene overexpression to the diverse DS phenotypes remain incompletely understood.
- Dosage-sensitive gene overexpression is a primary hypothesis, with complex gene and RNA interactions also contributing.
Purpose of the Study:
- To review evidence on how the overexpression of specific genes contributes to Down syndrome phenotypes.
- To investigate the role of the G-protein-activated inward rectifying potassium type 2 (GIRK2) channel subunit in DS.
- To explore the potential contribution of GIRK2 coupling to GABA(B) receptors in DS-related disabilities.
Main Methods:
- Review of existing scientific literature and evidence.
- Analysis of gene expression patterns in Down syndrome.
- Examination of molecular interactions between GIRK2 and GABA(B) receptors.
Main Results:
- Overexpression of dosage-sensitive genes is a likely driver of DS phenotypes.
- Evidence suggests the GIRK2 gene is overexpressed in DS.
- The coupling of GIRK2 with GABA(B) receptors is implicated in neurological and functional impairments.
Conclusions:
- The overexpression of the GIRK2 gene subunit is a significant factor contributing to the spectrum of mental and functional disabilities in Down syndrome.
- Understanding the GIRK2-GABA(B) receptor interaction provides insights into DS pathophysiology.
- Further research into specific gene contributions can illuminate therapeutic targets for Down syndrome.
Related Concept Videos
Activation and Inactivation of G Proteins
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
TGF - β Signaling Pathway
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Meiosis I

